Blue Whale Capital LLP Idexx Laboratories Inc Transaction History

Blue Whale Capital LLP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 10, 2023	BUY	$450.7 - $503.61 $2.59 Million - $2.9 Million	5,750 Added 11.68%	55,000 $27.6 Million
Q1 2023 May 15, 2023	SELL	$406.01 - $514.59 $15.7 Million - $19.9 Million	-38,750 Reduced 44.03%	49,250 $24.6 Million
Q4 2022 Feb 14, 2023	BUY	$324.64 - $441.27 $7.3 Million - $9.93 Million	22,500 Added 34.35%	88,000 $35.9 Million
Q3 2022 Nov 14, 2022	SELL	$325.8 - $407.78 $2.93 Million - $3.67 Million	-9,000 Reduced 12.08%	65,500 $21.3 Million
Q2 2022 Aug 12, 2022	SELL	$327.37 - $553.44 $11.5 Million - $19.4 Million	-35,000 Reduced 31.96%	74,500 $26.1 Million
Q1 2022 May 16, 2022	BUY	$466.52 - $631.01 $22.6 Million - $30.6 Million	48,500 Added 79.51%	109,500 $59.9 Million
Q4 2021 Feb 11, 2022	BUY	$586.54 - $666.48 $35.8 Million - $40.7 Million	61,000 New	61,000 $40.2 Million

1,212

72.5M

167K

343K

Ticker IDXX
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 83,253,696
Market Cap $34.3B
Description
IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through CAG; Water Quality Products; LPD; and Other segments. It provides point-of-care veterinary diagnostic products, inclu...

Get notified when there are updates to the investment portfolio of Blue Whale Capital LLP, based on Form 13F filings with the SEC.

Stay updated on Blue Whale Capital LLP with notifications on news.